BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+31.1%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$901M
AUM Growth
+$901M
Cap. Flow
-$91.2M
Cap. Flow %
-10.12%
Top 10 Hldgs %
81.99%
Holding
29
New
3
Increased
5
Reduced
1
Closed
5

Top Buys

1
AMRN
Amarin Corp
AMRN
$21.2M
2
PTCT icon
PTC Therapeutics
PTCT
$12M
3
DBVT
DBV Technologies
DBVT
$9.77M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$6.13M
5
SLDB icon
Solid Biosciences
SLDB
$4.79M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
$49.6M
2
VKTX icon
Viking Therapeutics
VKTX
$35.6M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
$26.6M
4
MGNX icon
MacroGenics
MGNX
$25.7M
5
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
$20.1M

Sector Composition

1 Healthcare 95.18%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SLDB icon
1
Solid Biosciences
SLDB
$427M
$136M 15.09% 2,881,600 +101,600 +4% +$4.79M
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$108M 12.04% 630,000 – –
PTCT icon
3
PTC Therapeutics
PTCT
$3.92B
$101M 11.24% 2,155,000 +255,000 +13% +$12M
WVE icon
4
Wave Life Sciences
WVE
$1.53B
$79.5M 8.83% 1,590,600 – –
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$73.7M 8.18% 1,565,560 – –
ESPR icon
6
Esperion Therapeutics
ESPR
$448M
$61M 6.77% 1,375,000 – –
ODT
7
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$54.9M 6.09% 2,826,938 – –
RCKT icon
8
Rocket Pharmaceuticals
RCKT
$354M
$48.4M 5.37% 1,966,051 – –
MDCO
9
DELISTED
Medicines Co
MDCO
$41.9M 4.65% 1,400,000 +150,000 +12% +$4.49M
DBVT
10
DBV Technologies
DBVT
$264M
$33.7M 3.74% 1,500,000 +435,000 +41% +$9.77M
RETA
11
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$32.7M 3.63% 400,000 +75,000 +23% +$6.13M
KNSA icon
12
Kiniksa Pharmaceuticals
KNSA
$2.48B
$29.9M 3.32% 1,172,700 – –
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
$23.2M 2.57% 2,094,000 – –
AMRN
14
Amarin Corp
AMRN
$311M
$21.2M 2.35% +1,300,000 New +$21.2M
KURA icon
15
Kura Oncology
KURA
$686M
$14.8M 1.64% 844,789 – –
MEIP icon
16
MEI Pharma
MEIP
$160M
$12.6M 1.39% 2,913,091 – –
RIGL icon
17
Rigel Pharmaceuticals
RIGL
$697M
$7.45M 0.83% 2,321,900 – –
KALV icon
18
KalVista Pharmaceuticals
KALV
$678M
$4.42M 0.49% +200,000 New +$4.42M
VIRX
19
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.25M 0.47% 2,125,000 – –
RGLS
20
DELISTED
Regulus Therapeutics
RGLS
$4.03M 0.45% 1,697,802 – –
XENE icon
21
Xenon Pharmaceuticals
XENE
$2.98B
$3.96M 0.44% +300,000 New +$3.96M
BLPH
22
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1.6M 0.18% 1,482,143 -375,000 -20% -$405K
ELDN icon
23
Eledon Pharmaceuticals
ELDN
$155M
$1.52M 0.17% 324,383 – –
SNDX icon
24
Syndax Pharmaceuticals
SNDX
$1.41B
$808K 0.09% 100,000 – –
MDGL icon
25
Madrigal Pharmaceuticals
MDGL
$9.76B
– – -95,000 Closed -$26.6M
1
2